Paige E Lysne

Paige E Lysne, MPH, CCRC, ACRP-CP

Study Coordinator III

Department: HA-UFHCI CRO PEDIATRICS
Business Phone: (352) 294-8743
Business Email: plysne@ufl.edu

On This Page

Publications

Academic Articles

  1. Effects of Prefrontal Transcranial Direct Current Stimulation on Retention of Performance Gains on an Obstacle Negotiation Task in Older Adults.

    Journal
    Neuromodulation : journal of the International Neuromodulation Society.
    Volume/Issue
    26(4):829-839
    [DOI]
    10.1016/j.neurom.2022.02.231.
    [PMID]
    35410769.
  2. Somatosensory impairment of the feet is associated with higher activation of prefrontal cortex during walking in older adults.

    Journal
    Experimental gerontology.
    Volume/Issue
    165
    [DOI]
    10.1016/j.exger.2022.111845.
    [PMID]
    35644417.
  3. Adaptability and Resilience in Aging Adults (ARIAA): protocol for a pilot and feasibility study in chronic low back pain.

    Journal
    Pilot and feasibility studies.
    Volume/Issue
    7(1)
    [DOI]
    10.1186/s40814-021-00923-y.
    [PMID]
    34666839.
  4. Pain and the Montreal Cognitive Assessment (MoCA) in Aging.

    Journal
    Pain medicine (Malden, Mass.).
    Volume/Issue
    22(8):1776-1783
    [DOI]
    10.1093/pm/pnab003.
    [PMID]
    33718961.
  5. Combining Frontal Transcranial Direct Current Stimulation With Walking Rehabilitation to Enhance Mobility and Executive Function: A Pilot Clinical Trial.

    Journal
    Neuromodulation : journal of the International Neuromodulation Society.
    Volume/Issue
    24(5):950-959
    [DOI]
    10.1111/ner.13250.
    [PMID]
    32808403.
  6. Obstacle Negotiation in Older Adults: Prefrontal Activation Interpreted Through Conceptual Models of Brain Aging.

    Journal
    Innovation in aging.
    Volume/Issue
    4(4)
    [DOI]
    10.1093/geroni/igaa034.
    [PMID]
    32995566.
  7. Age and pain differences in non-verbal fluency performance: Associations with cortical thickness and subcortical volumes.

    Journal
    Experimental gerontology.
    Volume/Issue
    126
    [DOI]
    10.1016/j.exger.2019.110708.
    [PMID]
    31445107.

Grants

  1. A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML

    Active

    Role:
    Other
    Funding:
    BLOOD CANCER UNITED
  2. A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

    Active

    Role:
    Other
    Funding:
    PUBLIC HLTH INST via SERVIER PHARMACEUTICALS
  3. A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

    Active

    Role:
    Other
    Funding:
    PUBLIC HLTH INST via JAZZ PHARMACEUTICALS
  4. A PHASE II, RANDOMIZED, OPEN-LABEL STUDY TO ASSESS THE EFFICACY, SAFETY, AND PHARMACOKINETICS (PK) OF MAINTENANCE CABOZANTINIB (XL184) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS BSC IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (AYA) WITH UNRESECTABLE RESIDUAL OSTEOSARCOMA EITHER AT DIAGNOSIS OR AT FIRST RELAPSE AFTER STANDARD TREATMENT

    Active

    Role:
    Other
    Funding:
    PAREXEL INTERNATIONAL PTY via IPSEN BIOPHARMACEUTICALS

Contact Details

Phones:
Business:
(352) 294-8743
Emails:
Business:
plysne@ufl.edu
Addresses:
Business Mailing:
1600 SW ARCHER RD # M354
GAINESVILLE FL 32610
Business Street:
1600 SW ARCHER RD
GAINESVILLE FL 32610